StonvexLoading…
StonvexStonvexStonvexCore line items from SMXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $90.98M | $22.99M | $54.14M | $44.72M |
Operating Income | $-6.30M | $-33.10M | $483.85K | $-7.97M |
Net Income | $-6.33M | $-34.96M | $434.79K | $-6.87M |
EPS (Diluted) | $-0.13 | $-0.79 | $0.01 | $-0.17 |
Total Assets | $91.29M | $38.63M | $48.66M | $61.48M |
Total Liabilities | $103.50M | $53.71M | $64.54M | $77.69M |
Cash & Equivalents | $7.97M | $786.33K | $2.54M | $3.82M |
Free Cash Flow OCF − CapEx | Not available | $-9.13M | $4.06M | $-2.06M |
Shares Outstanding | 54.91M | 45.27M | 39.74M | 39.74M |